[Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions].
The development of highly active antiretroviral therapy has greatly improved HIV-infected patient survival. However, the increased life expectancy associated with the management of opportunistic infections might favour the onset of severe organic failure that could require organ transplantation. The use of immunosuppressive drugs in association with antiretroviral therapy will generate pharmacodynamic and pharmacokinetic interactions. In this context, therapeutic drug monitoring is of great importance to improve therapeutic management of patients.
Moretto
Johnny
J
Laboratoire de Pharmacologie-Toxicologie, Laboratoire HP2, INSERM ERI017, Université de Médecine, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
Bessard
Germain
G
Stanke-Labesque
Françoise
F
D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001711:Biotransformation; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D007166:Immunosuppressive Agents